TrialStem cell research & therapy2022

Safety and efficacy of autologous, adipose-derived mesenchymal stem cells in patients with rheumatoid arthritis: a phase I/IIa, open-label, non-randomized pilot trial.

Ridhima Vij et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.